92
Participants
Start Date
November 8, 2022
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2025
Hemay005 tablets
Hemay005 tablets (15mg/tablet)will be orally administered twice daily.
Hemay005 placebo tablets
Hemay005 placebo tablets will be orally administered twice daily.
The Fourth Affiliated Hospital of Anhui Medical University, Hefei
The First Affiliated Hospital of Fujian Medical University, Fuzhou
The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou
First Affiliated Hospital of Zhengzhou University, Zhengzhou
Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Xiangya Hospital of Central South University, Changsha
The First Affiliated Hospital of Nanchang University, Nanchang
Shengjing Hospital Affiliated to China Medical University, Shenyang
Qilu Hospital of Shandong University, Jinan
Shandong Provincial Hospital, Jinan
Sichuan Provincial People's Hospital, Chengdu
First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Beijing Chaoyang Hospital Affiliated to Capital Medical University, Beijing
Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing
Peking University Third Hospital, Beijing
Chongqing People's Hospital, Chongqing
Shanghai Oriental Hospital, Shanghai
Tianjin Medical University General Hospital, Tianjin
Lead Sponsor
Ganzhou Hemay Pharmaceutical Co., Ltd
INDUSTRY